Evidence map›Paper›PMID 30842657›Full record

ArticleNature2019

TRAIP is a master regulator of DNA interstrand crosslink repair.

R Alex Wu, Daniel R Semlow, Ashley N Kamimae-Lanning, Olga V Kochenova, Gheorghe Chistol, Michael R Hodskinson, Ravindra Amunugama, Justin L Sparks, Meng Wang, Lin Deng and 4 more

Open access · greenAbstract read
In one paragraph

Article in Nature, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 122 papers.

0numbers the graph read from it
0cells of the map it votes in
122citing papers in PubMed
9.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

122 citing papers in PubMed, 183 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Reconstitution of genome remodeling usingFrontiers in cell and developmental biology · 2026
    Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article

62 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 5 institutions in 2 countries.

R Alex WuDepartment of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA.
Daniel R SemlowDepartment of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA.
Ashley N Kamimae-LanningMRC Laboratory of Molecular Biology, Cambridge Biomedical Campus, Cambridge, UK.
Olga V KochenovaDepartment of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA.
Gheorghe ChistolDepartment of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA.
Michael R HodskinsonMRC Laboratory of Molecular Biology, Cambridge Biomedical Campus, Cambridge, UK.
Ravindra AmunugamaDepartment of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA.
Justin L SparksDepartment of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA.
Meng WangMRC Laboratory of Molecular Biology, Cambridge Biomedical Campus, Cambridge, UK.
Lin DengDepartment of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA.
Claudia A MimosoDepartment of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA.
Emily LowDepartment of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA.
Ketan J PatelMRC Laboratory of Molecular Biology, Cambridge Biomedical Campus, Cambridge, UK.
Johannes C WalterDepartment of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA. johannes_walter@hms.harvard.edu.
Harvard University · USMRC Laboratory of Molecular Biology · GBUniversity of Cambridge · GBDana-Farber Cancer Institute · USHoward Hughes Medical Institute · US

Funding

The Fanconi anemia pathway: role in DNA interstrand cross-link repairR01HL098316 · NHLBI · HARVARD MEDICAL SCHOOL · PI Johannes Walter · 2010 to 2026
$6.3M
Mechanism of NEIL3-dependent ICL repairR00GM129422 · NIGMS · CALIFORNIA INSTITUTE OF TECHNOLOGY · PI SEMLOW, DANIEL · 2020 to 2022
$747k
Mechanism of NEIL3-dependent ICL repairK99GM129422 · NIGMS · HARVARD MEDICAL SCHOOL · PI SEMLOW, DANIEL · 2018 to 2019
$180k
Ubiquitylation and Helicase Unloading in Eukaryotic DNA Replication TerminationF31GM122277 · NIGMS · HARVARD MEDICAL SCHOOL · PI LOW, EMILY · 2017 to 2018
$69k
Howard Hughes Medical InstituteMedical Research Council MC_U105178811NHLBI NIH HHS R01 HL098316NIGMS NIH HHS F31 GM122277NIGMS NIH HHS K99 GM129422NIGMS NIH HHS R00 GM129422
6 · The paper itself

Abstract

Cells often use multiple pathways to repair the same DNA lesion, and the choice of pathway has substantial implications for the fidelity of genome maintenance. DNA interstrand crosslinks covalently link the two strands of DNA, and thereby block replication and transcription; the cytotoxicity of these crosslinks is exploited for chemotherapy. In Xenopus egg extracts, the collision of replication forks with interstrand crosslinks initiates two distinct repair pathways. NEIL3 glycosylase can cleave the crosslink

Indexed as

DNA RepairAnimalsDNADNA HelicasesDNA ReplicationFemaleHumansMinichromosome Maintenance Complex Component 7N-Glycosyl HydrolasesProtein BindingUbiquitinUbiquitinationUbiquitin-Protein LigasesXenopusDNADNA HelicasesMCM7 protein, humanMinichromosome Maintenance Complex Component 7NEIL3 protein, humanN-Glycosyl HydrolasesTRAIP protein, humanUbiquitinUbiquitin-Protein Ligases

Identifiers

PMID30842657
PMCPMC6417926
OpenAlexW2919113889

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.